The decline in PDS Biotechnology's share price is directly linked to the announcement of their Q4 financial results. Typically, financial performance announcements have a significant impact on stock prices, especially if the results are below market expectations. The immediate negative reaction suggests that the results may not have met investor expectations, leading to a decrease in stock value.